DPP3 binders directed to and binding to specific DPP3 epitopes, and their use in the prevention or treatment of diseases / acute conditions associated with oxidative stress.
Binders targeting DPP3 epitopes, such as anti-DPP3 antibodies, address the regulatory role of DPP3 in oxidative stress, effectively treating associated diseases and conditions by modulating DPP3 activity.
JP7875894B2Inactive Publication Date: 2026-06-184ティーン4ファーマシューティカルズゲゼルシャフトミットベシュレンクテルハフツング
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- 4ティーン4ファーマシューティカルズゲゼルシャフトミットベシュレンクテルハフツング
- Filing Date
- 2024-01-18
- Publication Date
- 2026-06-18
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 0007875894000024 
Figure 0007875894000025 
Figure 0007875894000026
Abstract
To provide a binder directed to and binding to a DPP3 protein or functional derivative thereof and its use in a method of prevention or treatment of diseases or acute conditions in a patient, wherein the disease or acute condition is associated with oxidative stress.SOLUTION: With this context, specifically, the present invention provides a binder being directed to and binding to an epitope according to a specific sequence, wherein the epitope is comprised in a DPP3 protein or a functional derivative thereof, and wherein the DPP3 binder recognizes and binds to at least three amino acids within a specific sequence.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art